Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
Authors
Keywords
CD44, Prognosis, Meta-analysis, Overall survival, Disease-free survival
Journal
Cancer Cell International
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-06-17
DOI
10.1186/s12935-016-0325-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma
- (2014) Shuai Hu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma
- (2013) H Okabe et al. BRITISH JOURNAL OF CANCER
- Expression of stemness markers (CD133 and EpCAM) in prognostication of hepatocellular carcinoma
- (2013) Anthony W H Chan et al. HISTOPATHOLOGY
- CD44s Regulates the TGF- -Mediated Mesenchymal Phenotype and Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
- (2012) K. Mima et al. CANCER RESEARCH
- Biology and clinical implications of CD133+ liver cancer stem cells
- (2012) Stephanie Ma EXPERIMENTAL CELL RESEARCH
- Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma
- (2012) Zheng-Jun Zhou et al. INTERNATIONAL JOURNAL OF CANCER
- Role of CD44 expression in non-tumor tissue on intrahepatic recurrence of hepatocellular carcinoma
- (2012) Lkhagva-Ochir Tovuu et al. International Journal of Clinical Oncology
- Role of CD44 in tumour progression and strategies for targeting
- (2012) Lalit Mohan Negi et al. JOURNAL OF DRUG TARGETING
- A CD44high/EGFRlow Subpopulation within Head and Neck Cancer Cell Lines Shows an Epithelial-Mesenchymal Transition Phenotype and Resistance to Treatment
- (2012) Linnea La Fleur et al. PLoS One
- Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors
- (2012) Yu-Mei Liang WORLD JOURNAL OF GASTROENTEROLOGY
- Expression of the Transmembrane Glycoprotein CD44s Is Potentially an Independent Predictor of Recurrence in Hepatocellular Carcinoma
- (2011) Han Suk Ryu et al. Gut and Liver
- Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
- (2011) Miranda Ween et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interactions between cancer stem cells and their niche govern metastatic colonization
- (2011) Ilaria Malanchi et al. NATURE
- CD44 Is Protective during Hyperoxia-Induced Lung Injury
- (2010) Gerritje J. W. van der Windt et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma
- (2010) Satoru Hagiwara et al. JOURNAL OF GASTROENTEROLOGY
- CD44 variant isoforms in head and neck squamous cell carcinoma progression
- (2009) Steven J. Wang et al. LARYNGOSCOPE
- CD44 is of Functional Importance for Colorectal Cancer Stem Cells
- (2008) L. Du et al. CLINICAL CANCER RESEARCH
- Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
- (2008) Christine E. Eyler et al. JOURNAL OF CLINICAL ONCOLOGY
- Osteopontin Combined with CD44, a Novel Prognostic Biomarker for Patients with Hepatocellular Carcinoma Undergoing Curative Resection
- (2008) G.-H. Yang et al. ONCOLOGIST
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started